TMS therapy for Coral Springs — outpatient TRD care, 35 minutes from home.

RECO Integrated Psychiatry sits 35 minutes from Coral Springs via the Sawgrass Expressway — close enough for a daily six-week TMS course without hospital-clinic overhead. The psychiatry team documents TRD candidacy, runs prior authorization for Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS, and delivers the FDA-cleared 10 Hz protocol at 120% motor threshold in-office. Clients from Eagle Trace, Parkland Isles, and Heron Bay drive themselves in, return to work the same day, and stay with their existing therapist through the six-week course.

Coral Springs sits 25 miles inland from RECO Integrated Psychiatry’s Delray Beach office — roughly 35 minutes on the Sawgrass Expressway and I-95, longer in afternoon traffic. For adults in Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, and Heron Bay who have cycled through two or more antidepressants without adequate response, that drive is what makes an outpatient TMS therapy course workable: 36 sessions across six to nine weeks in a specialist psychiatry office, not a hospital neuromodulation suite, and no PHP or IOP enrollment attached.

Insurance-covered TRD candidacy and how RECO documents it

Commercial coverage for repetitive TMS in treatment-resistant major depressive disorder is gated on documentation. Most Florida payers — Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and the BCBS national plans — require evidence of two adequate antidepressant trials from at least two different pharmacologic classes: adequate dose, adequate duration (typically six weeks or longer), and adequate adherence. Adequate trials usually include SSRIs (sertraline, escitalopram, fluoxetine), SNRIs (venlafaxine, duloxetine), and often at least one augmentation trial with aripiprazole, quetiapine, or lithium. A documented course of psychotherapy — most commonly CBT — is also required.

At the initial consult, RECO’s psychiatry team reconstructs the trial history in the format the specific payer requires, pulls prior authorization diagnoses (F33.1 or F33.2 for recurrent MDD), and submits PHQ-9 scoring at intake and at each payer-required rescoring interval. For clients whose treatment history is scattered across a primary care physician, a former psychiatrist, and a therapist who prescribed nothing, this reconstruction is part of the intake — not homework sent back to the client to chase down.

Motor threshold mapping and the first week of treatment

Session one is not treatment. It is motor threshold determination: the minimum stimulator output that reliably evokes a visible twitch in the right abductor pollicis brevis when the coil is positioned over the left motor cortex. That threshold anchors every subsequent session. Standard treatment intensity is set at 120% of MT and delivered over the left dorsolateral prefrontal cortex, localized by the Beam F3 method or scalp measurement.

Sessions two through five are the acclimation window. Scalp discomfort under the coil — sometimes described as a woodpecker sensation — is most notable in the first three or four sessions and typically fades as the scalp desensitizes. Some clients take acetaminophen 30 minutes prior for the first week; that request is routine. There is no sedation, no IV, no cognitive testing, and no post-treatment monitoring. Clients drive themselves in, sit in a treatment chair, and drive themselves home or back to work.

Standard 10 Hz protocol versus intermittent theta burst

The standard FDA-cleared protocol for rTMS in MDD is 10 Hz stimulation, 3,000 pulses per session, delivered in a 20 to 40 minute window. It is what most commercial policies default to and what most published response data reflects. Intermittent theta burst (iTBS) is an FDA-cleared alternative — 600 pulses in a three-minute session — with efficacy comparable to standard 10 Hz in the THREE-D non-inferiority trial and subsequent registry data.

For clients in Coral Springs coordinating a daily six-week course around work or childcare, the difference between a 40-minute chair time and a three-minute chair time is often what makes the course feasible. Not every commercial plan reimburses iTBS at the same rate as standard 10 Hz, and some require a specific rationale attached to prior authorization. RECO confirms iTBS coverage with the specific payer before scheduling rather than pivoting mid-course. Deep TMS on the H1 or H7 coil is also available for MDD and for OCD, respectively, when a client presents with a primary YBOCS-driven indication.

Response, taper, and the retreatment question

Published response rates for rTMS in treatment-resistant depression run 40 to 60 percent; remission rates 25 to 40 percent. Response — defined as a 50 percent reduction in PHQ-9 or MADRS from baseline — most commonly emerges between sessions 15 and 25, not in the first two weeks. Clients who feel nothing at session 10 are not failures; the protocol is designed for a delayed response curve, and premature discontinuation is one of the most common preventable reasons for non-response.

The final six of the 36 sessions are a taper: three sessions per week, then two, then one, spread across the last two to three weeks. Responders who later relapse — typically 6 to 12 months after the initial course — are candidates for a second full course. Payers generally cover retreatment on documentation of prior response, a sustained interval remission, and current relapse to a defined PHQ-9 threshold. RECO’s psychiatry team handles the retreatment prior authorization the same way it handled the first, and clients who responded to iTBS the first time are typically retreated on the same protocol.

What the first visit looks like

The intake is a 60 to 90 minute psychiatric evaluation with a prescribing clinician, not a sales conversation with an intake coordinator. The clinician reviews medication trials, prior response, side effects that ended each trial (sexual side effects on sertraline, weight gain on mirtazapine, activation on venlafaxine, cognitive blunting on higher-dose SSRIs), current medications, family psychiatric history, and any bipolar-spectrum features that would shift the clinical picture toward mood stabilization before neuromodulation. PHQ-9 and GAD-7 are administered at intake; ASRS if adult ADHD is a differential; YBOCS if OCD is the primary target for deep TMS.

Concurrent medication is typically maintained during a TMS course. Clients on an SSRI, SNRI, or bupropion generally stay on it. Benzodiazepines and anticonvulsants (gabapentin, lamotrigine, valproate) can raise motor threshold and blunt cortical response; the clinician reviews whether any current medication warrants a taper before starting. The plan the client leaves with is specific: which protocol, how prior authorization will move, an estimated start date, and a session cadence that fits the daily drive from Coral Springs.

Insurance and logistics from Coral Springs

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and the major BCBS plans for outpatient psychiatry and TMS. Copays, deductibles, and out-of-pocket maxima vary by plan; the billing team runs a benefits check before the consult and provides a written estimate before the first treatment session, not after.

For the drive itself, morning appointments before 8 a.m. or after 10 a.m. avoid the worst of I-95 southbound congestion out of Broward County. The Sawgrass Expressway route from Parkland and northern Coral Springs is usually cleaner than the Turnpike at rush hour. Six weeks of daily driving is real; families in Eagle Trace and Heron Bay often stack the appointment at the same clock time each morning to protect the rest of the day, and telepsychiatry is used for medication management follow-ups between the initial consult and any post-course maintenance.

Serving residents of: Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, Heron Bay.